Announcements

The Foundation’s Role in Advancing Medical Product Development in the United States
Read More
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
Read More
Call for Nominations for the 2026 Innovations in Regulatory Science & Policy Awards
The Reagan-Udall Foundation for the FDA invites nominations for its annual Innovations in Regulatory Science & Policy Awards.
Read More
More Announcements

Coverage

BRC Therapeutics Joins FDA And EMA Regulators At Workshop Advancing The Future Of Botanical Drug Development
The workshop also builds on an invitation-only botanical drug development roundtable that the FDA's Center for Drug Evaluation and Research convened with the Reagan-Udall Foundation for the FDA.
Read More
The FDA Promises To Streamline the Dauntingly Complex Rules for Approving Nicotine Products
A 2022 analysis by the Reagan-Udall Foundation noted that the FDA had "struggled to function as a regulator in part due to some of its policy choices," including the "scope of the product review regulations," which "have been difficult for both…
Read More
BioFuture 2026 Convenes Industry Leaders in New York City to Explore the Trends Reshaping Biopharma and Healthcare
Next Wave of Innovation: Navigating Policy and Regulatory Headwinds, featuring Cartier Esham, Esham Strategies; Jennifer Hawks Bland, NewYorkBIO; William Soliman, ACMA; Blake Wilson, Hogan Lovells Cadwalader; and Susan Winckler, Reagan-Udall Foundation…
Read More
More Coverage